| 755 |
Centers for Disease Control and Prevention |
Html |
en |
Make 2016 Your Year to Quit | CDC Features |
Quit Smoking to start your year off right. |
| free service | 0.364963 |
| health care provider | 0.757856 |
| burning cigarettes | 0.350845 |
| family member | 0.349444 |
| body | 0.256924 |
| resolution | 0.264008 |
| additional support online | 0.507311 |
| helpful online | 0.349165 |
| nicotine replacement therapies | 0.489395 |
| preventable disease | 0.390818 |
| powerfully addictive drug | 0.485269 |
| coaching | 0.258717 |
| quit plan | 0.930742 |
| Smokefree App | 0.441257 |
| nicotine inhalers | 0.390629 |
| Beatrice | 0.483833 |
| quit date | 0.679072 |
| Smokers TM campaign | 0.560323 |
| letter | 0.260203 |
| healthier life | 0.357614 |
| program sends encouragement | 0.487473 |
| Spanish speakers | 0.371835 |
| United States | 0.388155 |
| greatest motivator | 0.374555 |
| educational materials | 0.36221 |
|
| cigarette smoker | 0.38614 |
| exciting things | 0.38837 |
| effective quit plan | 0.79177 |
| control cravings | 0.364676 |
| varenicline | 0.235135 |
| U.S. smokers | 0.444207 |
| great idea | 0.370726 |
| smoking | 0.980206 |
| Online help | 0.380966 |
| free app | 0.362765 |
| smoking triggers | 0.527371 |
| Smokefree TXT | 0.445099 |
| common smoking medications | 0.617606 |
| CDC’s Tips | 0.364365 |
| New York | 0.381973 |
| smokefree progress | 0.418951 |
| main thing | 0.368045 |
| doctor | 0.257518 |
| free resources | 0.602092 |
| nasal spray | 0.353801 |
| smoking patterns | 0.498778 |
| Smokers web page | 0.533866 |
| Drug Administration-approved NRTs | 0.465632 |
| text QUIT | 0.634319 |
|
CLICK HERE |
| 818 |
Centers for Disease Control and Prevention |
Html |
en |
Notifiable Diseases and Mortality Tables |
Table I Summary of provisional cases of selected notifiable diseases, United States, cumulative, week ending January 18, 2014 (3rd Week). |
| different event codes | 0.546801 |
| H. influenzae | 0.452363 |
| CDC | 0.414052 |
| California serogroup | 0.55608 |
| age group | 0.387684 |
| novel influenza | 0.703217 |
| invasive pneumococcal disease | 0.892885 |
| eastern equine | 0.380257 |
| measles cases | 0.488963 |
| ** Data | 0.425291 |
| western equine diseases | 0.534069 |
| case notifications | 0.390439 |
| susceptible cases | 0.444658 |
| probable cases | 0.461634 |
| Rocky Mountain | 0.373758 |
| rickettsia infections | 0.425981 |
| ArboNET Surveillance | 0.380001 |
| Zoonotic | 0.241021 |
| rubella cases | 0.457909 |
| Spotted fever rickettsioses | 0.610947 |
| St. Louis | 0.383265 |
| E. coli | 0.385299 |
| influenza A virus | 0.548185 |
| virus infections | 0.44249 |
|
| National Center | 0.576427 |
| Immunization | 0.238697 |
| cases | 0.716494 |
| pneumoniae invasive disease | 0.605104 |
| Table | 0.294832 |
| Total case counts | 0.562767 |
| Spotted fever group | 0.60869 |
| serogroup non-O157 | 0.555819 |
| serotypes | 0.23788 |
| Shiga | 0.291467 |
| similar clinical presentation | 0.533031 |
| Vector-Borne Infectious Diseases | 0.573027 |
| meningococcal disease | 0.401093 |
| Cumulative total E. | 0.561785 |
| condition | 0.258155 |
| Influenza Division | 0.512298 |
| Streptococcus | 0.243131 |
| unknown serogroup | 0.556482 |
| Respiratory Diseases | 0.40228 |
| Powassan | 0.245724 |
| ages | 0.237911 |
| Enteric Diseases | 0.39817 |
| Includes drug resistant | 0.552698 |
|
CLICK HERE |
| 6008 |
Centers for Disease Control and Prevention |
Html |
en |
Chlorodifluoromethane - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 7545 |
Centers for Disease Control and Prevention |
Html |
en |
ADHD - Research |
ADHD is one of the most common neurobehavioral disorders of childhood. It is usually first diagnosed in childhood and often lasts into adulthood. Children with ADHD have trouble paying attention, controlling impulsive behaviors (may act without thinking about what the result will be), and in some cases, are overly active. |
| CDC’s research | 0.582572 |
| CDC | 0.583577 |
| large number | 0.564878 |
| state Medicaid programs | 0.614551 |
| health plans | 0.603836 |
| Medicaid drug | 0.560496 |
| Mental Health | 0.563271 |
| ADHD medications | 0.875742 |
| state program | 0.562733 |
| unanswered questions | 0.558898 |
| school-age children | 0.570137 |
| children | 0.70379 |
| study team | 0.598671 |
| Current medical research | 0.598609 |
| medication treatment | 0.566419 |
| treatment patterns | 0.560058 |
| national surveys | 0.629005 |
| diverse population groups | 0.588081 |
| overview page | 0.563273 |
| Prescription prior-authorization policy | 0.605665 |
| special health care | 0.607015 |
| ADHD symptoms | 0.806985 |
| population-based research project | 0.604483 |
| specific medications | 0.55986 |
| risks children | 0.566768 |
|
| ADHD | 0.998718 |
| United States | 0.610093 |
| Oklahoma Health Sciences | 0.605596 |
| Attention-deficit/hyperactivity disorder | 0.566746 |
| national study | 0.561 |
| cross-sectional mapping study | 0.609105 |
| substantial financial savings | 0.600561 |
| best treatments | 0.565097 |
| comprehensive information | 0.560294 |
| state programs | 0.562318 |
| ADHD medication | 0.840254 |
| ADHD treatment policy | 0.832187 |
| public health prevention | 0.606398 |
| public health | 0.648776 |
| prior-authorization policies | 0.683709 |
| children’s health | 0.581048 |
| Learn About Youth | 0.561104 |
| Public health issues | 0.604055 |
| state policies | 0.567839 |
| healthcare claims datasets | 0.597385 |
| Medicaid prior-authorization policies | 0.618015 |
| treatment costs | 0.563578 |
| public health problem | 0.631719 |
| information | 0.573058 |
|
CLICK HERE |
| 8938 |
Centers for Disease Control and Prevention |
Html |
en |
Vaccine Information Statement: MMRV (Measles, Mumps, Rubella, Varicella) - Vaccines - CDC |
MMRV (Measles, Mumps, Rubella and Varicella) Vaccine Information Statement |
| Permanent brain damage | 0.515311 |
| runny nose | 0.482647 |
| Page | 0.525199 |
| National Vaccine Injury | 0.603838 |
| severe skin infection | 0.567063 |
| ear infection | 0.479473 |
| Vaccine Information Statements | 0.620813 |
| severe allergies | 0.497328 |
| severe allergic reaction | 0.747585 |
| children | 0.537592 |
| severe problems | 0.532414 |
| eye irritation | 0.482611 |
| seizures | 0.491977 |
| rubella | 0.475944 |
| fever-related seizures | 0.487321 |
| Mild rash | 0.486629 |
| varicella vaccine | 0.608211 |
| painful swelling | 0.488472 |
| chickenpox blisters | 0.481303 |
| Vaccine Adverse Event | 0.594944 |
| diseases | 0.471802 |
| Mild problems | 0.478935 |
| brain damage | 0.619406 |
| varicella vaccines | 0.789381 |
| separate shots | 0.678706 |
|
| VAERS website | 0.475108 |
| life-threatening allergic reaction | 0.652246 |
| low platelet count | 0.650082 |
| dose | 0.609359 |
| previous dose | 0.522929 |
| problems | 0.544583 |
| child | 0.489177 |
| swollen glands | 0.484649 |
| United States | 0.474855 |
| painful rash | 0.496697 |
| Long-term seizures | 0.477222 |
| MMRV vaccine | 0.983876 |
| mild fever | 0.498362 |
| state health department | 0.519856 |
| spinal cord | 0.475481 |
| Current Edition Date | 0.548714 |
| immune system problems | 0.477592 |
| severe allergic reactions | 0.673165 |
| Temporary low platelet | 0.519781 |
| certain vaccines | 0.500091 |
| birth defects | 0.478057 |
| doctor | 0.498926 |
| antibiotic neomycin | 0.474305 |
| Moderate problems | 0.477264 |
|
CLICK HERE |
| 9863 |
Centers for Disease Control and Prevention |
Html |
en |
Enteric Diseases Epidemiology Branch - DFWED - NCEZID |
CDC's lead epidemiology and surveillance group for tracking pathogens and identifying sources for bacterial enteric (intestinal) infections transmitted by food and other routes. |
| rapid response | 0.488783 |
| CDC | 0.274974 |
| sources | 0.296588 |
| United States | 0.503271 |
| environments | 0.250436 |
| close collaboration | 0.488989 |
| prevention tools | 0.488448 |
| bacterial infections | 0.622123 |
| body | 0.252267 |
| better science | 0.495214 |
| routes | 0.262642 |
| emergencies | 0.265981 |
| pathogens | 0.28357 |
| central values | 0.488727 |
| contact | 0.28476 |
| state health departments | 0.725351 |
| Enteric bacteria | 0.654714 |
| animals | 0.250529 |
| bacterial diarrheal illness | 0.850708 |
|
| cases | 0.24927 |
| scientific rigor | 0.531733 |
| countries | 0.248536 |
| thousands | 0.250799 |
| associated deaths | 0.523 |
| prevention measures | 0.481517 |
| water | 0.250684 |
| infected person | 0.532639 |
| illness burden | 0.722955 |
| foodborne illness | 0.60656 |
| mouth | 0.26862 |
| service | 0.246239 |
| surveillance group | 0.579377 |
| lead epidemiology | 0.565639 |
| national goals | 0.489298 |
| millions | 0.269556 |
| regulatory agencies | 0.486372 |
| feces | 0.308294 |
|
CLICK HERE |
| 12442 |
Centers for Disease Control and Prevention |
Video |
en |
Way to Go: Passport To Health |
Health experts suggest that you take several key steps to be protected against injury or illness when travelling to developing nations. This includes packing a health kit, bringing medications, and getting immunizations for safe and healthy travel.
Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html
This video can also be viewed at http://www.cdc.gov/cdctv/PassportToHealth |
| Passport | 0.989449 |
| Health | 0.667064 |
|
|
CLICK HERE |
| 13495 |
Centers for Disease Control and Prevention |
Html |
en |
Laboratory Safety Workgroup |
Laboratory Safety Workgroup members |
| additional safeguards | 0.282944 |
| CDC | 0.797455 |
| necessary actions | 0.274695 |
| ACD’s recommendations | 0.392851 |
| H5N1 influenza-containing laboratory | 0.354074 |
| laboratory safety improvements | 0.381981 |
| follow-up report | 0.43985 |
| Associate Director | 0.337891 |
| laboratory science | 0.362761 |
| internal staff | 0.280432 |
| CDC BSL-2 facilities | 0.528673 |
| CDC’s Office | 0.472069 |
| new recommendations | 0.299902 |
| CDC Progress | 0.523168 |
| follow-up report. | 0.291555 |
| ACD Recommendations Concerning | 0.459452 |
| Plant Health Inspection | 0.327695 |
| stronger safeguards | 0.286905 |
| extensive staff engagement | 0.336571 |
| safety staff | 0.296747 |
| laboratory safety culture | 0.400387 |
| CDC’s progress | 0.592217 |
| CDC’s laboratories | 0.486193 |
| safety policies | 0.304103 |
|
| necessary safeguards | 0.286234 |
| Laboratory Safety Progress | 0.460155 |
| incident reporting | 0.278768 |
| external BSL-3 laboratory | 0.35076 |
| ELSW members | 0.278468 |
| Safety Progress Update | 0.451683 |
| laboratory work | 0.297813 |
| CDC BSL-3 facility | 0.528247 |
| Advisory Committee | 0.406401 |
| Concerning Laboratory Safety | 0.486177 |
| ) laboratories. | 0.282026 |
| viable Bacillus anthracis | 0.334085 |
| additional findings | 0.272593 |
| CDC laboratories | 0.566041 |
| newly formed Office | 0.33556 |
| key laboratory safety | 0.387303 |
| Laboratory Safety Workgroup | 0.431811 |
| CDC Laboratory Safety | 0.627864 |
| external experts | 0.285791 |
| laboratory safety | 0.94153 |
| ongoing procedural reviews | 0.323602 |
| Laboratory Safety Recommendations | 0.408899 |
| best practices | 0.279316 |
| corrective actions | 0.278192 |
|
CLICK HERE |
| 13573 |
Centers for Disease Control and Prevention |
Video |
en |
Are You Listening? PSA (:30) |
This public service announcement encourages women to learn the symptoms of gynecologic cancer and pay attention to what their bodies are telling them.
Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html
This video can also be viewed at
http://www.cdc.gov/wcms/videos/low-res/NCCDPHP/2015/ayl_video_english_30_925657.mp4 |
|
|
CLICK HERE |
| 14057 |
Centers for Disease Control and Prevention |
Html |
en |
Malaria - Travelers - Malaria Information and Prophylaxis, by Country |
Red Pages Malaria Information and Prophylaxis, by Country. |
| glucose-6-phosphate dehydrogenase | 0.432018 |
| ovale rare Atovaquone-proguanil | 0.758678 |
| Nusa Tenggara Timur | 0.582624 |
| Sistan-Baluchestan Province | 0.450442 |
| current medical history | 0.50508 |
| previous adverse reactions | 0.500906 |
| Ujung Kulong | 0.438228 |
| Chloroquine P. vivax | 0.85949 |
| local weather conditions | 0.518895 |
| Moderate Chloroquine P. | 0.605235 |
| P. malariae | 0.571822 |
| India All areas | 0.479009 |
| Vatican City | 0.433079 |
| higher transmission intensity | 0.528959 |
| small focal areas | 0.544665 |
| travelAltitude information | 0.445103 |
| Fars Province | 0.445687 |
| Kerman Provinces | 0.451064 |
| P. falciparum | 0.969299 |
| Maluku Utara | 0.465468 |
| International Travel | 0.467878 |
| Iran Rural areas | 0.555934 |
| Indonesia All areas | 0.467352 |
| rural areas | 0.635585 |
|
| Papua Barat | 0.449882 |
| CDC Health Information | 0.575084 |
| Taranto Province | 0.443776 |
| insufficient information | 0.433773 |
| malaria map | 0.553248 |
| malaria species | 0.503169 |
| P. falciparum malaria | 0.894149 |
| Labuan Bajo | 0.440426 |
| certain province Map | 0.554187 |
| Nusa Tenggara Barat | 0.591955 |
| Pulau Seribu | 0.430379 |
| best available data | 0.507879 |
| P. knowlesi | 0.472119 |
| significant malaria transmission | 0.617335 |
| Low transmission | 0.459825 |
| Nusa Tengarra region | 0.576278 |
| Komodo Islands | 0.432685 |
| Himachal Pradesh | 0.445618 |
| agricultural areas | 0.45737 |
| Gili Islands | 0.43681 |
| Yellow Book | 0.435653 |
| resort areas | 0.461311 |
| malaria transmission patterns | 0.631081 |
|
CLICK HERE |